Pál Gyulavári MTA-SE Pathobiochemistry Research Group Semmelweis University Biography Publications Institution JoVE Articles Pál Gyulavári has not added a biography. If you are Pál Gyulavári and would like to personalize this page please email our Author Liaison for assistance. Publications Synthesis, Characterization and Systematic Comparison of FITC-labelled GnRH-I, -II and -III Analogues on Various Tumour Cells Journal of Peptide Science : an Official Publication of the European Peptide Society. Aug, 2016 | Pubmed ID: 27443981 Correction: Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro PloS One. 2015 | Pubmed ID: 26672602 Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes in Vitro PloS One. 2015 | Pubmed ID: 25874616 Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors ACS Medicinal Chemistry Letters. Apr, 2014 | Pubmed ID: 24900830 [Development and Biochemical Characterization of EGFR/c-Met Dual Inhibitors] Acta Pharmaceutica Hungarica. 2013 | Pubmed ID: 24575658 In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues József Murányi1,2, Attila Varga1, Bianka Gurbi1, Pál Gyulavári1, Gábor Mező3, Tibor Vántus2 1MTA-SE Pathobiochemistry Research Group, Semmelweis University, 2Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, 3MTA-ELTE Research Group of Peptide Chemistry, Eötvös Loránd University JoVE 55529 Cancer Research
In Vitro Imaging and Quantification of the Drug Targeting Efficiency of Fluorescently Labeled GnRH Analogues József Murányi1,2, Attila Varga1, Bianka Gurbi1, Pál Gyulavári1, Gábor Mező3, Tibor Vántus2 1MTA-SE Pathobiochemistry Research Group, Semmelweis University, 2Department of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, 3MTA-ELTE Research Group of Peptide Chemistry, Eötvös Loránd University JoVE 55529 Cancer Research
